SecBot SecBot
8-K ·Filed Mar 5, 2026

OSUR

ORASURE TECHNOLOGIES INC
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago SEC0001116463-26-000011
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

Monitor for any subsequent appointments to the board or Compensation Committee, as well as potential changes in corporate governance or strategy that may follow this departure.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.19
T+0 close · Mar 5, 2026 · via day close
Latest settled
+28.21%
T+60 · $4.09
Vs SPY
+15.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 6 $3.19entry
  2. T+1 · 8mo ago +0.31%α −0.53% · $3.20
  3. T+5 · 8mo ago −6.90%α −5.37% · $2.97
  4. T+20 · 8mo ago −3.45%α −1.40% · $3.08
  5. T+60 · 6mo ago +28.21%α +15.43% · $4.09
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

David J. Shulkin, M.D. resigned from his position as a director and member of the Compensation Committee of OraSure Technologies, Inc., effective March 2, 2026. The resignation was not due to any dispute or disagreement with the company.

Key Facts

  • Dr. David J. Shulkin resigned as director and member of the Compensation Committee effective March 2, 2026.
  • Resignation was voluntary and not due to any disagreement with the board, management, or company.
  • No immediate replacement was announced.
  • The company expressed appreciation for Dr. Shulkin's years of service.

Financial Impact

No direct financial impact disclosed.

Risk Factors

  • Potential loss of strategic guidance given Dr. Shulkin's background, though risk is mitigated by the amicable nature of the departure.
  • Board composition changes could influence future compensation decisions or oversight.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001116463-26-000011
Document: 0001116463-26-000011-index-headers.html0001116463-26-000011
Document: 0001116463-26-000011-index.html0001116463-26-000011
Document: 0001116463-26-000011.txt0001116463-26-000011

Track record

20 reports on OSUR

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
  2. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
  3. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 2/10 Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
  5. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
  6. Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
  7. Jul 23, 202616w ago Court Ruling Neutral 3/10 Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
  8. Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
  9. Jun 3, 202623w ago 8-K Neutral 3/10 Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
  10. May 6, 202627w ago 8-K Bearish 6/10 Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 5, 2026